

Cover Story
By Matthew Bin Han Ong
After an examination of the causes of an avalanche of grant applications directed at NCI, institute officials found that new applications largely come from principal investigators who are switching their research focus to cancer. No other NIH institute or center faces such pressure.
In Brief
Funding Opportunities
Clinical Roundup


Drugs & Targets


NCI Trials


NCI Trials for December 2019
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
Trending Stories
- GRAIL to use new study results to seek FDA approval of Galleri MCD test
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- Duke brain cancer researcher Kyle Walsh named director of NIEHS
- Cancer centers adapt to life without site visits as NIH changes CCSG review
- Trump cuts IVF drug deal with Merck in exchange for tariff exemption
- Jonathan Licht named president, chief scientific officer at Van Andel Institute















